NEW YORK (GenomeWeb News) — Illumina today said fourth-quarter revenues jumped 163 percent as R&D spending rose 17 percent and profit soared.
Total receipts for the three months ended Dec. 31, 2006, increased to $60.4 million from $23 million year over year.
R&D spending increased to $8.8 million from $7.5 million year over year.
The company said profit increased to $17.1 million from $326,000 in the year-ago period.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.